4 free views remaining today
polyhydramnios
ICD-10 Codes
Related ICD-10:
Description
Polyhydramnios, also known as hydramnios, is a condition characterized by an abnormally large amount of amniotic fluid surrounding the fetus in the womb [3]. This excess fluid can put pressure on the mother's organs and potentially cause complications during pregnancy [5].
The symptoms of polyhydramnios may include:
- A larger than normal uterus for the stage of pregnancy
- Stomach discomfort or pain
- Shortness of breath
- Swelling in the feet, ankles, and vulva
- Decreased urine production
In severe cases, polyhydramnios can lead to premature labor pains [1]. It is essential to note that not all cases of polyhydramnios will exhibit outward symptoms, and some may only be detected through ultrasound or other medical tests.
Polyhydramnios can be caused by various factors, including:
- Maternal diabetes
- Fetal anomalies or genetic conditions
- Multiple pregnancy (twins, triplets, etc.)
- Placental problems
Early detection and proper management of polyhydramnios are crucial to prevent potential complications and ensure a healthy outcome for both the mother and the baby [4].
References:
[1] Context result 1: Stomach discomfort, premature labor pains, larger than normal uterus, shortness of breath. [2] Context result 2: Discomfort in the abdomen. [3] Context result 3: Defined by an amniotic fluid index that is above the 95th centile. [4] Context result 4: Increased amniotic fluid develops in the uterus during pregnancy. [5] Context result 5: Shortness of breath, swelling in the feet, ankles, and vulva, decreased urine production.
Additional Characteristics
- Shortness of breath
- An abnormally large amount of amniotic fluid surrounding the fetus in the womb
- A larger than normal uterus for the stage of pregnancy
- Stomach discomfort or pain
- Swelling in the feet, ankles, and vulva
- Decreased urine production
- Premature labor pains
- Maternal diabetes
- Fetal anomalies or genetic conditions
- Multiple pregnancy (twins, triplets, etc.)
- Placental problems
Signs and Symptoms
Polyhydramnios, also known as excessive amniotic fluid, can cause a range of symptoms in pregnant women. Here are some common signs and symptoms:
- Belly pain or tightness: This is one of the most common symptoms of polyhydramnios, caused by the uterus expanding to accommodate the excess fluid [1][2].
- Difficulty breathing: In severe cases, polyhydramnios can cause uterine distention, leading to difficulty breathing and/or painful preterm contractions [3].
- Indigestion, upset stomach or constipation: Some women may experience gastrointestinal symptoms due to the pressure exerted by the expanding uterus on the digestive system [4][5].
- Increased or decreased urine production: Women with polyhydramnios may experience changes in their urinary habits, either producing more or less urine than usual [6].
- Swelling in the lower extremities: Swelling in the feet and ankles can occur due to fluid retention [7].
It's essential for pregnant women to be aware of these symptoms and seek medical attention if they experience any of them. In many cases, slight polyhydramnios goes away by itself, but severe cases may require medical intervention.
References: [1] Context result 3 [2] Context result 4 [3] Context result 5 [4] Context result 6 [5] Context result 7 [6] Context result 8
Additional Symptoms
- Difficulty breathing
- Belly pain or tightness
- Increased or decreased urine production
- Swelling in the lower extremities
- constipation
Diagnostic Tests
Polyhydramnios, also known as fetal hydrops or excessive amniotic fluid, can be diagnosed through various diagnostic tests.
Ultrasound Examination
The most reliable method for diagnosing and quantifying polyhydramnios is ultrasonography. Experienced operators make the diagnosis based on measurements of amniotic fluid volume, which can be done using two methods:
- Amniotic Fluid Index (AFI)
- Maximum Vertical Pocket (MVP)
These measurements help determine the severity of polyhydramnios and guide further management.
Other Diagnostic Tests
While ultrasound is the primary diagnostic tool for polyhydramnios, other tests may be ordered to rule out underlying fetal or maternal conditions that could be contributing to the excessive amniotic fluid. These include:
- Karyotyping: A genetic test to identify chromosomal abnormalities in the fetus.
- Array testing: A genetic test to detect specific genetic mutations or deletions in the fetus's DNA.
- DNA testing: To confirm the presence of certain genetic conditions, such as myotonic dystrophy.
Diagnostic Criteria
Polyhydramnios is typically diagnosed when there is an excessive amount of amniotic fluid volume (AFV) detected by a quantitative ultrasound technique. The exact criteria for diagnosis may vary depending on the institution and the specific circumstances of each case.
Sources:
- [1] Ultrasonography is the most reliable method for diagnosing and quantifying polyhydramnios.
- [3] Experienced operators make the diagnosis based on measurements of amniotic fluid volume.
- [5] Prenatal diagnosis is based upon documentation of excessive amniotic fluid volume (AFV) by a quantitative ultrasound technique, such as AFI or MVP.
- [7] The diagnosis of polyhydramnios is made via ultrasound examination.
Treatment
Treatment Options for Polyhydramnios
Polyhydramnios, a condition characterized by an excessive amount of amniotic fluid, can be treated with various methods, including drug therapy.
- Indomethacin: This is the most commonly used medication to treat polyhydramnios. It works by reducing the production of prostaglandins, which are hormone-like substances that stimulate the uterus to contract and produce amniotic fluid. Studies have shown that indomethacin can be highly effective in treating polyhydramnios, with success rates ranging from 90-100% [1].
- Prostaglandin Synthetase Inhibitor: Indomethacin is a prostaglandin synthetase inhibitor, which means it blocks the production of prostaglandins. This can help reduce the amount of amniotic fluid in the uterus [8].
Other Treatment Options
While drug therapy is often effective, other treatment options may be necessary in some cases.
- Transabdominal Amnioinfusion: In severe cases of polyhydramnios, transabdominal amnioinfusion may be used to instill a small amount of fluid into the uterus. This can help improve visualization for ultrasonography and increase the amniotic fluid volume [9].
Important Considerations
It's essential to note that treatment with indomethacin or other medications should only be done under strict medical supervision, as it carries potential risks and side effects.
- Monitoring Schedule: A strict monitoring schedule should be followed whenever indomethacin is administered to ensure the mother's and fetus's safety [2].
In some cases, treating the underlying condition (such as diabetes) may also be necessary to manage polyhydramnios.
- Management and Treatment: Treatment may be needed if you have severe polyhydramnios. In some cases, that means treating the underlying condition [7].
Recommended Medications
- Prostaglandin Synthetase Inhibitor
- Transabdominal Amnioinfusion
- indometacin
- Indomethacin
๐ Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Polyhydramnios, a condition characterized by an excessive amount of amniotic fluid in the uterus during pregnancy, can have various underlying causes. Here are some potential differential diagnoses for polyhydramnios:
- Fetal malformations: Polyhydramnios is frequently seen in patients with diabetes in pregnancy, as well as in cases of fetal malformations [1].
- Twin to twin transfusion syndrome (TTTS): In twin pregnancies, TTTS is an important differential diagnosis of excessive amniotic fluid volume, especially when there are discrepancies in fetal growth or development [8].
- Maternal diabetes: Polyhydramnios can be associated with maternal diabetes, particularly if the condition is not well-managed [1].
- Fetal anomalies: Certain fetal anomalies, such as esophageal atresia or duodenal atresia, can lead to polyhydramnios due to impaired swallowing and digestion of amniotic fluid [3].
- Chromosomal abnormalities: Polyhydramnios has been reported in association with chromosomal abnormalities, such as trisomy 21 (Down syndrome) [4].
It's essential to note that a comprehensive evaluation by a healthcare provider is necessary to determine the underlying cause of polyhydramnios and develop an appropriate treatment plan.
References:
[1] G Nicolae ยท 2019 ยท Cited by 4 โ ABSTRACT Polyhydramnios is frequently seen in patients with diabetes in pregnancy, as well as in cases of fetal malformations. [3] Oct 17, 2008 โ Polyhydramnios occurs as a result of either increased production or decreased removal of amniotic fluid. The etiology of polyhydramnios can be ... [4] Jun 1, 2006 โ From a clinical perspective, polyhydramnios results from an overproduction of amniotic fluid or an interruption in the removal of fluid from the ...
Additional Differential Diagnoses
- **Fetal malformations**: Polyhydramnios is frequently seen in patients with diabetes in pregnancy, as well as in cases of fetal malformations
- *Twin to twin transfusion syndrome (TTTS)*: In twin pregnancies, TTTS is an important differential diagnosis of excessive amniotic fluid volume, especially when there are discrepancies in fetal growth or development
- **Maternal diabetes**: Polyhydramnios can be associated with maternal diabetes, particularly if the condition is not well-managed
- *Fetal anomalies*: Certain fetal anomalies, such as esophageal atresia or duodenal atresia, can lead to polyhydramnios due to impaired swallowing and digestion of amniotic fluid
- *Chromosomal abnormalities*: Polyhydramnios has been reported in association with chromosomal abnormalities, such as trisomy 21 (Down syndrome)
- congenital secretory sodium diarrhea 8
- congenital disorder of glycosylation type IIa
- congenital disorder of glycosylation If
- congenital disorder of glycosylation In
- obsolete Vasa previa complicating labor and delivery
- esophageal atresia
- obsolete Fetal Macrosomia
- obsolete perinatal disease
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:8488
- core#notation
- DOID:8488
- oboInOwl#hasDbXref
- UMLS_CUI:C0020224
- IAO_0000115
- A placenta disease that is characterized by an excess of amniotic fluid in the amniotic sac.
- rdf-schema#label
- polyhydramnios
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_780
- relatedICD
- http://example.org/icd10/O40
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_13224
- owl#annotatedSource
- t451412
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.